SB 515
Requiring drug testing for individuals receiving office-based medication-assisted treatment
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House of Delegates
- To Governor
- Became Law
Bill overview
This bill would require individuals receiving medication-assisted treatment in an office-based setting in West Virginia to undergo regular drug testing as part of their treatment program. The testing schedule would vary depending on the phase of treatment – initial admission, stabilization, and maintenance – with both definitive and presumptive tests utilized. The goal is to monitor patient compliance with the treatment program and ensure continued sobriety.
Key provisions
- Require a comprehensive drug test upon initial admission to an office-based medication-assisted treatment program.
- Mandate direct observation, definitive drug tests every two weeks for six weeks following initial admission.
- Require direct observation, presumptive drug tests every 45 days for one year during the stabilization phase.
- Establish a schedule of presumptive drug tests every six months during the maintenance phase until discharge.
- Allow providers to request confirmatory testing if a presumptive test indicates a potential issue.
- Patients must consent to provide a test upon request.
Who is affected
- Individuals receiving medication-assisted treatment
- Office-based medication-assisted treatment providers
- Patients with substance use disorders
Notable changes
- Introduces a mandatory drug testing component for patients in office-based medication-assisted treatment programs.
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yours